Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

被引：2
|
作者：
Chatterjee, Saurav [1 ]
Maitra, Subhankar [1 ]
Chakraborty, Anasua [2 ]
机构：
[1] Maimonides Hosp, Brooklyn, NY 11219 USA
[2] Univ Connecticut, Farmington, CT USA
来源：
AMERICAN HEART JOURNAL | 2012年 / 163卷 / 01期
关键词：
D O I：
10.1016/j.ahj.2011.10.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E1 / E1
页数：1
相关论文
共 50 条
  • [21] Individualizing Dual Antiplatelet Therapy (DAPT) Duration Based on Bleeding Risk, Ischemic Risk, or Both: An Analysis From the DAPT Study
    Mihatov, Nino
    Secemsky, Eric A.
    Kereiakes, Dean J.
    Steg, P. Gabriel
    Cutlip, Donald E.
    Kirtane, Ajay J.
    Mehran, Roxana
    Zhao, Bokai
    Song, Yang
    Gibson, C. Michael
    Yeh, Robert W.
    [J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2022, 41 : 105 - 112
  • [22] Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial
    Aronow, Herbert D.
    Steinhubl, Steven R.
    Brennan, Danielle M.
    Berger, Peter B.
    Topol, Eric J.
    [J]. AMERICAN HEART JOURNAL, 2009, 157 (02) : 369 - 374
  • [23] High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial
    Weber, Michael
    Bhatt, Deepak L.
    Brennan, Danielle M.
    Hankey, Graeme J.
    Steinhubl, Steven R.
    Johnston, S. Claiborne
    Montalescot, Gilles
    Mak, Koon-Hou
    Fox, Keith A. A.
    Easton, Donald J.
    Topol, Eric J.
    Hamm, Christian W.
    [J]. HEART, 2011, 97 (08) : 626 - 631
  • [24] Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9-to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial
    Li, Yi
    Jing, Quanmin
    Wang, Bing
    Wang, Xiaozeng
    Li, Jing
    Qiao, Shubing
    Chen, Shaoliang
    Angiolillo, Dominick J.
    Han, Yaling
    [J]. AMERICAN HEART JOURNAL, 2020, 228 : 1 - 7
  • [25] Efficacy and Safety of Clopidogrel in Acute Coronary Syndrome Patients at High Risk of Bleeding: Data from the CURE Trial
    Eikelboom, John W.
    Mehta, Shamir R.
    Fox, Keith A.
    Pogue, Janice
    Yusuf, Salim
    [J]. CIRCULATION, 2008, 118 (18) : S916 - S916
  • [26] Optimizing Antiplatelet Therapy in High-Risk Patients With Atrial Fibrillation Insights From Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)
    Seet, Raymond Chee-Seong
    Chen, Christopher P. L.
    [J]. STROKE, 2009, 40 (12) : 3883 - 3885
  • [27] Benefit-Risk Profile of Extended Dual Antiplatelet Therapy Beyond 1 Year in Patients With High Risk of Ischemic or Bleeding Events After PCI
    Wang, Hao-Yu
    Gao, Run-Lin
    Yin, Dong
    Xu, Bo
    Dou, Ke-Fei
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (17) : B26 - B26
  • [28] Benefit-risk profile of extended dual antiplatelet therapy beyond 1 year in patients with high risk of ischemic or bleeding events after PCI
    Wang, Hao-Yu
    Gao, Run-Lin
    Xu, Bo
    Yang, Yue-Jin
    Yin, Dong
    Wang, Yang
    Dou, Ke-Fei
    [J]. PLATELETS, 2021, 32 (04) : 533 - 541
  • [29] Effect of dual antiplatelet therapy prolongation in acute coronary syndrome patients with both high ischemic and bleeding risk: insight from the OPT-CAD study
    Na, Kun
    Qiu, Miaohan
    Wei, Ningxin
    Li, Jiayin
    Yan, Chenghui
    Li, Jing
    Li, Yi
    Han, Yaling
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [30] Aspirin vs. Clopidogrel as a Chronic maintenance monotherapy after PCI in patients with high ischemic risk and high bleeding risk: Subgroup analysis of the HOST-EXAM trial
    Park, K. W.
    Kang, J.
    Koo, B. K.
    Rhee, T. M.
    Yang, H. M.
    Won, K. B.
    Rha, S. W.
    Bae, J. W.
    Lee, N. H.
    Hur, S. H.
    Han, J. K.
    Shin, E. S.
    Kim, H. S.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43
12345